Diagnosis, prognosis and classification of early arthritis: results of a systematic review informing the 2016 update of the EULAR recommendations for the management of early arthritis-Reference-Cited by-同舟云学术

Diagnosis, prognosis and classification of early arthritis: results of a systematic review informing the 2016 update of the EULAR recommendations for the management of early arthritis

Published:2017-01 Issue:1 Volume:3 Page:e000406
ISSN:2056-5933
Container-title:RMD Open
language:en
Short-container-title:RMD Open

Author:

Hua Charlotte,Daien Claire I,Combe Bernard,Landewe Robert

Publisher

BMJ

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference97 articles.

1. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies;Lard;Am J Med,2001

2. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis;Nell;Rheumatology (Oxford),2004

3. The effectiveness of early treatment with ‘second-line’ antirheumatic drugs. A randomized, controlled trial;van der Heide;Ann Intern Med,1996

4. Delay in receiving rheumatology care leads to long-term harm;Bykerk;Arthritis Rheum,2010

5. Long-term impact of delay in assessment of patients with early arthritis;van der Linden;Arthritis Rheum,2010

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of the Keap1/Nrf2/HO-1 Pathway by “Tianyu” Pairing: Implications for Inflammation and Oxidative Stress in Rheumatoid Arthritis;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-08-26

2. Cachexia in preclinical rheumatoid arthritis: Longitudinal observational study of thigh magnetic resonance imaging from osteoarthritis initiative cohort;Journal of Cachexia, Sarcopenia and Muscle;2024-06-24

3. Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study;RMD Open;2024-06

4. Functional Significance of miR-4693-5p in Targeting HIF1α and Its Link to Rheumatoid Arthritis Pathogenesis;Non-Coding RNA;2024-04-10

5. Distinction and prognosis of early arthritis phenotypes: an analysis in three European cohorts;RMD Open;2023-11